These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3563881)

  • 1. [In-vivo marking of human tumors using BUDR for flow-cytometry determination of kinetic cell parameters].
    Kärcher H; McNally NJ; Wilson G; Kärcher KH; Pfragner R
    Strahlenther Onkol; 1987 Mar; 163(3):195-200. PubMed ID: 3563881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell proliferation and ploidy of human solid tumours: methodological experience with in vivo bromodeoxyuridine and DNA flow cytometry.
    Mazzini G; Danova M; Ferrari C; Giordano M; Dionigi P; Riccardi A
    Anal Cell Pathol; 1996 Mar; 10(2):101-13. PubMed ID: 8721953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.
    Wilson GD; McNally NJ; Dunphy E; Kärcher H; Pfragner R
    Cytometry; 1985 Nov; 6(6):641-7. PubMed ID: 4064843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Flow cytometric measurements of in vivo incorporated bromodeoxy- uridine into the DNA of experimental and human tumors].
    Kärcher H; McNally NJ; Wilson G; Kärcher KH; Pfragner R
    Wien Klin Wochenschr; 1985 Nov; 97(22):850-5. PubMed ID: 4082602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell proliferation of human leukemia and solid tumors studied with in vivo bromodeoxyuridine and flow cytometry.
    Giordano M; Riccardi A; Danova M; Brugnatelli S; Mazzini G
    Cancer Detect Prev; 1991; 15(5):391-6. PubMed ID: 1751950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
    Hass HG; Schmidt A; Nehls O; Kaiser S
    Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid in vitro bromodeoxyuridine labeling method for monitoring of therapy response in solid human tumors.
    Hemmer J
    Cytometry; 1990; 11(5):603-9. PubMed ID: 2379451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical results obtained with bromodeoxy uridine (BUdR) labelled tumors of the head and neck].
    Radner H; Kärcher H
    Dtsch Z Mund Kiefer Gesichtschir; 1990; 14(2):116-21. PubMed ID: 2102412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic heterogeneity of an experimental tumour revealed by BrdUrd incorporation and mathematical modelling.
    Bertuzzi A; Faretta M; Gandolfi A; Sinisgalli C; Starace G; Valoti G; Ubezio P
    Bull Math Biol; 2002 Mar; 64(2):355-84. PubMed ID: 11926121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of the phase of synthesis by means of bromodeoxyuridine. Its clinical application in oncology of the head and neck].
    Garin L; Barona R; O'Connor E; Armengot M; Basterra J
    An Otorrinolaringol Ibero Am; 1991; 18(6):563-74. PubMed ID: 1776663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of sampling time on assessment of potential doubling time.
    Høyer M; Bentzen SM; Salling LN; Overgaard J
    Cytometry; 1994 Jun; 16(2):144-51. PubMed ID: 7924683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo bromodeoxyuridine labelling index, AgNOR protein expression and DNA content in human tumours.
    Trerè D; Ceccarelli C; Danova M; Derenzini M
    Eur J Histochem; 1996; 40(1):17-26. PubMed ID: 8741096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry.
    Forster G; Cooke TG; Cooke LD; Stanton PD; Bowie G; Stell PM
    Br J Cancer; 1992 May; 65(5):698-702. PubMed ID: 1586597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Flow cytometry studies of incorporated bromodeoxyuridine (BUdR) in carcinoma of the oral cavity. A new method].
    Kärcher H; McNally NJ; Wilson G; Pfragner R
    Dtsch Z Mund Kiefer Gesichtschir; 1985; 9(5):327-30. PubMed ID: 3868460
    [No Abstract]   [Full Text] [Related]  

  • 15. [Flow cytometry for the determination of DNA in head and neck carcinomas].
    Labella T; Castro C; Porto I; Orodogoitia H; Regueiro B
    Acta Otorrinolaringol Esp; 1989 Dec; 40 Suppl 2():295-7. PubMed ID: 2627522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokinetic investigation of lung tumors using the anti-bromodeoxyuridine (BUdR) monoclonal antibody method: comparison with DNA flow cytometric data.
    Teodori L; Trinca ML; Goehde W; Hemmer J; Salvati F; Storniello G; Mauro F
    Int J Cancer; 1990 Jun; 45(6):995-1001. PubMed ID: 2161804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample.
    Eidukevicius R; Characiejus D; Janavicius R; Kazlauskaite N; Pasukoniene V; Mauricas M; Den Otter W
    BMC Cancer; 2005 Sep; 5():122. PubMed ID: 16176590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary study by flow cytometry of the cell cycle and DNA quantification in cytokeratin-positive cells in tumors of the head and neck].
    Górriz C; González FM; Castejón R; García-Berrocal JR; Durántez A; Vargas JA
    Acta Otorrinolaringol Esp; 1999 May; 50(4):296-304. PubMed ID: 10431079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prognostic role of the parameters of cellular kinetics in head and neck tumors treated solely by radiotherapy].
    Corvò R; Giaretti W; Sanguineti G; Geido E; Bacigalupo A; Franzone P; Mereu P; Garaventa G; Barbieri M; Vitale V
    Radiol Med; 1993; 86(1-2):135-42. PubMed ID: 8346344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA analysis of head and neck squamous cell carcinoma by flow cytometry.
    Lampe HB
    Laryngoscope; 1993 Jun; 103(6):637-44. PubMed ID: 8099190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.